The first truly evidence-based dermatology reference book
Increased patient focus
Three new chapters cover the delivery of best practice alongside eight new clinical chapters
Includes an interactive CD-ROM of the full text and a dedicated website
www.evidbasedderm.com for chapter updates
Evidence-based Dermatology is a unique book in the field of clinical dermatology. Written and edited by some of the world’s leading exponents of evidence-based dermatology, it takes a highly evidence-based approach to treatment of all the major and many of the less common skin conditions.The rigorous reviewing, appraisal of evidence and structured layout in the clinical chapters makes this book different from its few competitors. Best treatment recommendations are based on discussion of systematic reviews and randomized controlled using the case and question-based approach of trained researchers in evidence-based medicine.The text is enhanced with full colour illustrations introducing particular cases, and throughout tables and boxed text summarize the main conclusions, providing quick reference for clinical practice alongside the thorough research.What’s new for the second edition?
The new edition will be greatly expanded with 11 new chapters and more focus on patients. Special features include:New chapters on delivery of best practice:What makes a good case series?
How to assess evidence of educational and psychological interventions
How to assess evidence of organisation of careNew clinical chapters:Photoageing
MolesPort-wine stains and vascular malformationsCellulitis and erysipelasExanthematic reactionsPsychocutaneous diseaseHerpes simplexRarer skin diseasesPatient commentaries in the clinical chapters will address the growing movement in evidence-based medicine to involve patients in decision makingThe four chapters currently posted on the website www.evidbasedderm.com will be included in the bookAll existing chapters will be thoroughly updatedFully searchable CDRom of the full text, and the book’s dedicated update website continue as major added value featuresSales of the first editionLOE: 750 copiesWhy propose doubled sales for the second edition?
This proposal is for a LOE of 1500 copies. The first edition was published by BMJ Books with no strengths in dermatology. We were confident of making the book a success on the back the BMJ's reputation in EBM. However the book was published around the time when the future of the books division was under review and this certainly affected the marketing. It was launched at AAD 2003 but didn't get any other specific marketing, yet has sold half its print run in 2 years.Blackwell is a leading dermatology publisher globally. This book will complement Rook and can be promoted alongside all the Blackwell clinical dermatology books at the leading conventions, in joint mailings and email alerts. There is scope for publishing chapters in relevant journals, providing promotional opportunities both for the book and the journal.Reviewers' commentsRhett Drugge, Editor of the Electronic Textbook of Dermatology1 How relevant is the book to the intendedreadership?It appear to be very important, and will be afavorite of dermatology educators.2 Can you think of any other groups who mightfind the book useful?Insurance companies who wish to limit therapies anddiagnostic workups to those supported by the evidence.3 Is the book up to date?The concept is valid, but is perhaps has lost abit of favor. The chapters look a bit brief for theintended subjects. It is not clear how the clinicalchapters would differ from typical textbook chapters.4 Are the proposed length and format appropriatefor the subject and readership? If not, can yousuggest a better length and format?Well, you might limit the book to the discourses onevidence based dermatology concepts, with fewerexample chapters because the book tries to teachevaluation of the dermatology literature withattendant study design as well as dermatology. Theseare two distinct subjects.5 Would the proposed price be acceptable to the readership? If not, what would be a suitable price range?You have to ask yourselves, will yourreadership really want to be buying a dermatology textwhich competes with your "Textbook of Dermatology" ordo they wish to buy a monograph on evidence baseddermatology which is more akin to an installment ofClinics in Dermatology. The main gist appears to bethe latter with associated price pressure. Could thisbe better handled as a journal of evidence baseddermatology?6 Please list any competing titles you may beaware of, either recently published or being planned.I am unaware of competition to the title.Comment: this review has been shown to the editor. Regarding cuting down on clinical information: this is contrary to feedback we've had on the first edition, with readers especially appreciating the clinical information.Hwyel Williams' responses:Point 3 On chapters not being very different from other clinical textbook chapters "structure is very different in theway it forces authors to report evidence on benefits and harms"Point 4 On the methodology and clinical chapters being two different subjects: "I see the point, but we have always maintained that they are strongly related. Most derms do not know how to appraise, so they need a toolbox at the start. The main "meat" however is the rest. Perhaps these could be split into two books, each having different audiences, but I think that would be a shame"Point 5 On competing with Rook: "fair point about the Textbook - maybe we should call ours a textbook of evidence-based derm therapy to make it more distinct from the textbook, of which therapy comprises about 25% "Andrew Finlay, Professor of Dermatology, University of WalesHow relevant is the book to the intended readership?Very relevant indeed and should probably be required reading for dermatologists in training.2 Can you think of any other groups who might find the book useful?Epidemiologists in other medical fields apart from dermatology, general practitioners with a special interest in research in dermatology eg members of the Primary Care Dermatology Society, medical students, doctors and other research professionals employed by the pharmaceutical industry with an interest in dermatology.3 Is the book up to date?Yes, indeed it has been 'ahead of its time' in dermatology.4 Are the proposed length and format appropriate for the subject and readership? If not, can you suggest a better length and format?Yes.5 Would the proposed price be acceptable to the readership? If not, what would be a suitable price range?At a price of £150 I expect that purchases may be limited to departmental libraries rather than this book being bought by individuals.6 Please list any competing titles you may be aware of, either recently published or being planned.I am not aware of any.
Increased patient focus
Three new chapters cover the delivery of best practice alongside eight new clinical chapters
Includes an interactive CD-ROM of the full text and a dedicated website
www.evidbasedderm.com for chapter updates
Evidence-based Dermatology is a unique book in the field of clinical dermatology. Written and edited by some of the world’s leading exponents of evidence-based dermatology, it takes a highly evidence-based approach to treatment of all the major and many of the less common skin conditions.The rigorous reviewing, appraisal of evidence and structured layout in the clinical chapters makes this book different from its few competitors. Best treatment recommendations are based on discussion of systematic reviews and randomized controlled using the case and question-based approach of trained researchers in evidence-based medicine.The text is enhanced with full colour illustrations introducing particular cases, and throughout tables and boxed text summarize the main conclusions, providing quick reference for clinical practice alongside the thorough research.What’s new for the second edition?
The new edition will be greatly expanded with 11 new chapters and more focus on patients. Special features include:New chapters on delivery of best practice:What makes a good case series?
How to assess evidence of educational and psychological interventions
How to assess evidence of organisation of careNew clinical chapters:Photoageing
MolesPort-wine stains and vascular malformationsCellulitis and erysipelasExanthematic reactionsPsychocutaneous diseaseHerpes simplexRarer skin diseasesPatient commentaries in the clinical chapters will address the growing movement in evidence-based medicine to involve patients in decision makingThe four chapters currently posted on the website www.evidbasedderm.com will be included in the bookAll existing chapters will be thoroughly updatedFully searchable CDRom of the full text, and the book’s dedicated update website continue as major added value featuresSales of the first editionLOE: 750 copiesWhy propose doubled sales for the second edition?
This proposal is for a LOE of 1500 copies. The first edition was published by BMJ Books with no strengths in dermatology. We were confident of making the book a success on the back the BMJ's reputation in EBM. However the book was published around the time when the future of the books division was under review and this certainly affected the marketing. It was launched at AAD 2003 but didn't get any other specific marketing, yet has sold half its print run in 2 years.Blackwell is a leading dermatology publisher globally. This book will complement Rook and can be promoted alongside all the Blackwell clinical dermatology books at the leading conventions, in joint mailings and email alerts. There is scope for publishing chapters in relevant journals, providing promotional opportunities both for the book and the journal.Reviewers' commentsRhett Drugge, Editor of the Electronic Textbook of Dermatology1 How relevant is the book to the intendedreadership?It appear to be very important, and will be afavorite of dermatology educators.2 Can you think of any other groups who mightfind the book useful?Insurance companies who wish to limit therapies anddiagnostic workups to those supported by the evidence.3 Is the book up to date?The concept is valid, but is perhaps has lost abit of favor. The chapters look a bit brief for theintended subjects. It is not clear how the clinicalchapters would differ from typical textbook chapters.4 Are the proposed length and format appropriatefor the subject and readership? If not, can yousuggest a better length and format?Well, you might limit the book to the discourses onevidence based dermatology concepts, with fewerexample chapters because the book tries to teachevaluation of the dermatology literature withattendant study design as well as dermatology. Theseare two distinct subjects.5 Would the proposed price be acceptable to the readership? If not, what would be a suitable price range?You have to ask yourselves, will yourreadership really want to be buying a dermatology textwhich competes with your "Textbook of Dermatology" ordo they wish to buy a monograph on evidence baseddermatology which is more akin to an installment ofClinics in Dermatology. The main gist appears to bethe latter with associated price pressure. Could thisbe better handled as a journal of evidence baseddermatology?6 Please list any competing titles you may beaware of, either recently published or being planned.I am unaware of competition to the title.Comment: this review has been shown to the editor. Regarding cuting down on clinical information: this is contrary to feedback we've had on the first edition, with readers especially appreciating the clinical information.Hwyel Williams' responses:Point 3 On chapters not being very different from other clinical textbook chapters "structure is very different in theway it forces authors to report evidence on benefits and harms"Point 4 On the methodology and clinical chapters being two different subjects: "I see the point, but we have always maintained that they are strongly related. Most derms do not know how to appraise, so they need a toolbox at the start. The main "meat" however is the rest. Perhaps these could be split into two books, each having different audiences, but I think that would be a shame"Point 5 On competing with Rook: "fair point about the Textbook - maybe we should call ours a textbook of evidence-based derm therapy to make it more distinct from the textbook, of which therapy comprises about 25% "Andrew Finlay, Professor of Dermatology, University of WalesHow relevant is the book to the intended readership?Very relevant indeed and should probably be required reading for dermatologists in training.2 Can you think of any other groups who might find the book useful?Epidemiologists in other medical fields apart from dermatology, general practitioners with a special interest in research in dermatology eg members of the Primary Care Dermatology Society, medical students, doctors and other research professionals employed by the pharmaceutical industry with an interest in dermatology.3 Is the book up to date?Yes, indeed it has been 'ahead of its time' in dermatology.4 Are the proposed length and format appropriate for the subject and readership? If not, can you suggest a better length and format?Yes.5 Would the proposed price be acceptable to the readership? If not, what would be a suitable price range?At a price of £150 I expect that purchases may be limited to departmental libraries rather than this book being bought by individuals.6 Please list any competing titles you may be aware of, either recently published or being planned.I am not aware of any.